Hello, Sign in
My Account
My Account
New customer? Start here
| Catalog # | Availability | Size | Quantity | Unit Price | Save For Later Wish List | |
|---|---|---|---|---|---|---|
| RCP0986-5 | 7 days | 5 µg | $120.00 |
Select product before adding to cart
|
||
| RCP0986-20 | 7 days | 20 µg | $290.00 | |||
| RCP0986-1 | 7 days | 1 mg | $4,320.00 |
Product Overview | |
| Name | H3F3A Human |
|---|---|
| Description | |
| H3 Histone Family 3A Human Recombinant | |
| Accession (Primary) | P84243 |
| Introduction | |
| H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. H3N2 strain descended from H2N2by antigenic shift, in which genes from multiple subtypes re-assorted to form a new virus. Both the H2N2and H3N2 strains contained genesfrom avian influenzaviruses. | |
| Physical Appearance | |
| Sterile Filtered whitish (milky) solution. | |
| Formulation | |
| The H3N2 A/Brisbane/10/07 solution contains STE, 0.1% sodium azide (NaN3) and 0.005% thimerosal. | |
| Stability | |
| A/Brisbane/10/07 although stable 4°C for 4 weeks, should be stored below -18°C. Please prevent freeze-thaw cycles. | |
| Purity | |
| Greater than 90.0% as determined byAnalysis by SDS-PAGE. | |
| References | |
| Title : Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection publication : The Rockefeller University Press , doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link : H3N2 Brisbane prospec publication | |
| Inactivation | |
| Thimerosal and beta propiolactone treatment This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. | |
| Immunological Activity | |
| Tested with anti-influenza A monoclonal antibodies in ELISA. Serological studies of influenza A virus, immunogen for antibody production. | |
| Precautions | |
| H3F3A Human is for research use only and not for use in diagnostic or therapeutic procedures. | |
Target Information: ( P84243 ) | |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from ADMEbio to advance their research.
Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
Thank you,
ADMEbio Team
ADMEbio welcomes feedback from our customers.
Thank you,
ADMEbio Team
